"Executive Summary Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market: Growth Trends and Share Breakdown The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast period While preparing this professional and exhaustive...